Thursday, September 17, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatoryretatrutideeli lillyfdagray market

CBS: companies illegally sell unapproved Lilly drug retatrutide online

Report finds online sellers marketing Eli Lilly's investigational obesity candidate retatrutide, which has no FDA approval.

DO
By Daniel Okafor · Regulatory Correspondent
Sep 16 18:24 ETSource: CBS News

The wire

  1. 01CBS News reports companies are illegally selling unapproved retatrutide, an Eli Lilly investigational drug, online.
  2. 02Unapproved sales of an experimental peptide pose safety and enforcement concerns.
  3. 03Any FDA or Lilly enforcement response is not specified.

From the source

Companies illegally selling unapproved Eli Lilly weight loss drug Retatrutide online

Read at news.google.com
Source URL https://news.google.com/rss/articles/CBMimAFBVV95cUxNb1J4ZGlLSWsyQ0FNVklWMlVlUHV0ZERWVi1uYmNiOHBwczZ4Q1NxRVdyand0Rjl2SDZsaVVZNlF6S0hGVTN0aVI1RUxlaEtqYzVYcUlIeF9fM3hTVlhoTTUzcWM4Tko4ZnRrYzF3ZTZFandxZ0ZfSFNtTnZKSnA5YlcwcUdReGEwcDhPSVpLQm93YmFDc29zeA?oc=5